Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
Aquavit Pharmaceuticals, Inc. and Accelrys Software Inc. (NASDAQ: ACCL), a leader in scientific innovation lifecycle management software, have formed an alliance partnership towards the development of Aquavit's PITO-001 and MAV-403 products. The partner agreement was signed on September 12, 2012. Under the terms of the partnership, Aquavit will utilize the scientifically aware Accelrys Enterprise Platform to develop advanced medical software for cutting-edge personalized medicine.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.